Oncology trials face several challenges, including patient recruitment, regulatory hurdles, and the complexity of cancer as a disease. Recruiting enough participants can be difficult, especially for rare cancers. Regulatory requirements ensure safety but can also slow down the trial process. Moreover, cancer's heterogeneity means that treatments may work for some patients but not others, necessitating personalized approaches.
